Paediatric Neurology

Our goals are to improve the health and quality of life of children with neurological diseases and offer comprehensive care through collaboration across multidisciplinary teams. Thanks to the implementation of new diagnostic and therapeutic procedures, we can advance our knowledge of molecular causes of, and develop new treatment strategies for, early onset neurological diseases.

The Vall d'Hebron University Hospital has been designated as an ERN in Congenital metabolic diseases (MetabERN) by the European Commission; and the Catalan Health Service has appointed a XUEC for Minority Diseases with Epilepsy in the same hospital.
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 22.12.2022, 11:17
Share it

Notícies relacionades

Subscribe to our newsletters and be a part of Campus Life

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.